Skip to main content
. 2017 May 5;8(32):52923–52934. doi: 10.18632/oncotarget.17629

Figure 2. Expressions of OX-42 detected by immunohistochemistry among the control, sham and chronic constriction injury (CCI) groups.

Figure 2

Note: (A) expression of marrow OX-42 in each group detected by immunohistochemistry, Scale bar = 50 μm (× 200); (B) comparison of OX-42 positive cells in each group; *, P < 0.05 in comparison with the sham group.